The veterinary vaccines market is projected to reach US$ 15,536.38 million by 2028 from US$ 9,984.65 million in 2021; it is estimated to register a CAGR of 6.5% from 2021 to 2028.
Veterinary vaccines are parenteral products used to prevent infectious diseases caused by various pathogens. These vaccines protect animals from a variety of life-threatening diseases. Veterinary vaccines serve a critical role in ensuring the longevity, good health, and overall production of pets and livestock cost-effectively. The veterinary vaccines are classified as inactivated, live-attenuated, toxoid, and recombinant vaccines. Key factors driving the market's growth are the increasing incidence of zoonotic diseases and the rising prevalence of foodborne diseases and infections. However, strict government rules related to the usage of veterinary vaccines are hampering the market growth. The veterinary vaccines market, by region, is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM). North America dominates the global market due to increased adoption of companion animals, increased consumption of meat and milk, and increased understanding of the benefits of animal immunizations.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Veterinary Vaccines Market: Strategic Insights
Market Size Value in US$ 9,984.65 million in 2021 Market Size Value by US$ 15,536.38 million by 2028 Growth rate CAGR of 6.5% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Veterinary Vaccines Market: Strategic Insights
| Market Size Value in | US$ 9,984.65 million in 2021 |
| Market Size Value by | US$ 15,536.38 million by 2028 |
| Growth rate | CAGR of 6.5% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Veterinary Vaccines Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Incidence of Zoonotic Diseases
Animals carry hazardous bacteria, viruses, parasites, and fungi to people, resulting in illness. Such diseases are known as zoonotic diseases or zoonoses. The clinical effect of zoonotic illnesses may range from mild to severe and sometimes lead to death. Zoonotic illnesses are ubiquitous in the world. As per the Center for Disease Control (CDC) projections, >6 out of every 10 existing infectious diseases in people can spread through animals, and 3 out of every 4 new or future infectious diseases in people will come from animals. Moreover, in 2016, at least 55,000 individuals perished of rabies in Asia and Africa.
In the past decades, several new infectious human diseases causing viruses, such as Ebola virus, West Nile virus, Human Immunodeficiency Virus (HIV), Nipah virus, and Hantavirus infections, have evolved from animal reservoirs. Outbreaks, such as severe acute respiratory syndrome (SARS) and avian influenza, have underlined the potential of germs from animal reservoirs to adapt to human hosts. More than three-quarters of the human diseases that are new, emerging, or re-emerging at the beginning of the 21st century are caused by pathogens derived from animals or products of animal origin. According to the WHO, ~60% of new infectious diseases identified globally are zoonoses, and every year, over 1 billion cases of illness and millions of deaths occur from zoonoses. Over 30 novel human infections have been found in the previous three decades, and 75% of these are originated from animals. Hence, the emerging and re-emerging zoonotic illnesses propel the demand for animal health. Thus, companies produce improved medications and vaccines to aid animal owners or other stakeholders to maintain the overall health of animals. Therefore, the growth in the incidence of zoonotic diseases boosts the veterinary vaccines market growth.
Vaccine Type-Based Insights
The global veterinary vaccines market, based on vaccine type, is segmented into livestock vaccines, companion animal vaccines, and others. The livestock vaccines segment is likely to hold the largest market share in 2021. However, the companion animal segment is anticipated to register the highest CAGR of 7.0% during the forecast period.
Veterinary Vaccines Market, by Vaccine Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-Based Insights
The global veterinary vaccines market, based on technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and others. In 2021, the live attenuated vaccines segment is likely to hold the largest market share. However, the inactivated vaccines segment is expected to grow at the highest CAGR from 2021 to 2028.
The veterinary vaccines market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio worldwide and to meet the growing demand.
Geography
Geographically, the veterinary vaccines market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
COVID Impacts
The countries in Europe are highly affected due to the COVID-19 pandemic. To control the outbreak of virus various restrictions were imposed by the government. This led to disruption, limitation, challenges, and changes in each sector of every industry. Likewise, animal vaccines industry was also impacted by the pandemic. For instance, veterinary organizations overseas have recommended limiting animal patient care to acutely ill animals and emergencies. Furthermore, the lockdowns have led to rescheduling of annual checkup exams and elective vaccination procedures.
However, various key players have ensured the supply of animal vaccines as the governmental institutions across the globe are taking strict measures to maintain the supply to avoid zoonotic viruses from spreading into communities. However, the overall impact of COVID-19 on the animal vaccines market remains fairly negative, owing to fall in demand as veterinary visits are limited, and animal healthcare approach is changed to providing care to emergency cases and critically ill animals.
Company Profiles
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
- ImmuCell Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type and Technology
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
A Veterinary Vaccines is a sterile glass or plastic test tube with a stopper that creates a vacuum inside the tube so that a preset volume of liquid can be depicted. The Veterinary Vaccines prevents needle stick damage by preventing needles from coming in human contact and thus, adulteration. A double-pointed needle is fitted to a plastic tubular adapter in the vacuum blood collecting tube. Double pointed needles are available in numerous gauge sizes. The needle's length varies from 1 to 1 1/2 inches. Additional elements may be present in Veterinary Vacciness, which are used to preserve blood for treatment in a medical laboratory.
Key factors that are driving growth of the market are increasing incidence of zoonotic diseases and rising prevalence foodborne diseases and infections propel the market growth. However, strict government rules related to the usage of veterinary vaccines hamper the growth of the market.
The Veterinary Vaccines market is anticipated to grow around 6.5% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2021.
Boehringer Ingelheim International GmbH and Zoetis Inc., are the key players in the Veterinary Vaccines market.
Livestock vaccines segment market provides the most opportunity for growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Veterinary Vaccines Market – By Vaccine Type
1.3.2 Global Veterinary Vaccines Market – By Technology
1.3.3 Global Veterinary Vaccines Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Veterinary Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Veterinary Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Zoonotic Diseases
5.1.2 Rising Prevalence of Foodborne Diseases and Infections
5.2 Market Restraints
5.2.1 Strict Government Rules Related to Usage of Veterinary Vaccines
5.3 Market Opportunities
5.3.1 Growing Market in Untapped Economies
5.4 Future Trends
5.4.1 Rising Awareness Related to Diagnosis and Treatment of Infectious Diseases
5.5 Impact Analysis
6. Veterinary Vaccines Market– Global Analysis
6.1 Global Veterinary Vaccines Market Revenue Forecast and Analysis
6.2 Global Veterinary Vaccines Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Veterinary Vaccines Market Revenue and Forecasts To 2028– By Vaccine Type
7.1 Overview
7.2 Global Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
7.3 Livestock Vaccines
7.3.1 Overview
7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Bovine Vaccines
7.3.3.1 Overview
7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Small Ruminant Vaccines
7.3.4.1 Overview
7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Companion Vaccines
7.4.1 Overview
7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Feline Vaccines
7.4.3.1 Overview
7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Canine Vaccines
7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Other Companion Animal Vaccines
7.4.5.1 Overview
7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Others:
7.5.1 Overview
7.5.2 Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. Veterinary Vaccines Market Revenue and Forecasts To 2028 – Technology
8.1 Overview
8.2 Global Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.6 Recombinant Vaccines
8.6.1 Overview
8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
9. Veterinary Vaccines Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America: Veterinary Vaccines Market
9.1.1 Overview
9.1.2 North America: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.3.1 North America: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.3.2 North America: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (US$ Million)
9.1.4 North America: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.1.5 North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 US: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.5.1.2.1 US: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.5.1.2.2 US: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.5.1.3 US: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.1.5.2 Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 Canada: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.5.2.2.1 Canada: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.5.2.2.2 Canada: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.5.2.3 Canada: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.1.5.3 Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 Mexico: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.5.3.2.1 Mexico: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.5.3.2.2 Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.5.3.3 Mexico: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.2 Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028
9.2.1 Overview
9.2.2 Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3 Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
9.2.3.1 Europe: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.3.2 Europe: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.4 Europe: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5 Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
9.2.5.1 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1.1 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1.2 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
9.2.5.1.2.1 Germany: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.1.2.2 Germany: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.1.3 Germany: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5.2 France Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.2.1 France: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.2 France Veterinary Vaccines : Market, By Vaccine Type, 2019–2028 (USD Million)
9.2.5.2.2.1 France: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.2.2.2 France: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.2.3 France: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5.3 UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.1 UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.2 UK: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.2.5.3.2.1 UK: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.3.2.2 UK: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.3.3 UK: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5.4 Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.1 Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.2 Italy: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.2.5.4.2.1 Italy: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.4.2.2 Italy: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.4.3 Italy: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5.5 Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.1 Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.2 Spain: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.2.5.5.2.1 Spain: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.5.2.2 Spain: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.5.3 Spain: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.2.5.6 Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.2.5.6.2.1 Rest of Europe: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.2.5.6.2.2 Rest of Europe: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.2.5.6.3 Rest of Europe: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3 Asia Pacific: Veterinary Vaccines Market
9.3.1 Overview
9.3.2 Asia Pacific: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia Pacific: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.3.1 Asia Pacific: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.3.3.2 Asia Pacific: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.3.4 Asia Pacific: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3.5 Asia Pacific: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.2 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.2.1 China: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.2.1.1 China: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.2.1.2 China: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.3.5.2.2 China: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3.5.3 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.1 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.2 Japan: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.3.2.1 Japan: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.3.2.2 Japan: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.3.5.3.3 Japan: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3.5.4 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.4.1 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.4.2 India: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.4.2.1 India: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.4.2.2 India: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.3.5.4.3 India: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3.5.5 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.5.1 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.5.2 Australia: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.5.2.1 Australia: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.5.2.2 Australia: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.3.5.5.3 Australia: Veterinary Vaccines Market, by Technology , 2019–2028 (USD Million)
9.3.5.6 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.6.1 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.6.2 South Korea: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.6.2.1 South Korea: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.6.2.2 South Korea: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.3.5.6.3 South Korea: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.3.5.7 Rest of Asia Pacific: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.7.1 Rest of Asia Pacific: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.7.2 Rest of Asia Pacific: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.3.5.7.2.1 Rest of Asia Pacific: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.3.5.7.2.2 Rest of Asia Pacific: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.3.5.7.3 Rest of Asia Pacific: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.4 Middle East and Africa: Veterinary Vaccines Market
9.4.1 Overview
9.4.2 Middle East & Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.4.3.1 Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.3.2 Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.4 Middle East & Africa: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.4.5 Middle East & Africa: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.4.5.1 Saudi Arabia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.1.1 Saudi Arabia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.1.2 Saudi Arabia Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.4.5.1.2.1 Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.1.2.2 Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.1.3 Saudi Arabia: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.4.5.2 UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.2.1 UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.2.2 UAE Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.4.5.2.2.1 UAE Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.2.2.2 UAE Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.2.3 UAE: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.4.5.3 South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.3.1 South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.3.2 South Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.4.5.3.2.1 South Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.3.2.2 South Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.3.3 South Africa: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.4.5.4 Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.4.1 Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.4.2 Rest of Middle East & Africa Veterinary Vaccines Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
9.4.5.4.2.1 Rest of Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.4.2.2 Rest of Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.4.5.4.3 Rest of Middle East & Africa: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.5 South And Central America Veterinary Vaccines Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.3 South and Central America: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.5.3.1 South and Central America: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.5.3.2 South and Central America: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (US$ Million)
9.5.4 South and Central America: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.5.5 South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.1 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.2 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.1.2.1 Brazil: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.5.5.1.2.2 Brazil: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (US$ Million)
9.5.5.1.3 Brazil: Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2 Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.1 Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.2 Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.2.2.1 Argentina: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.5.5.2.2.2 Argentina: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (US$ Million)
9.5.5.2.3 Argentina: Veterinary Vaccines Market Revenue and Forecasts To 2028, By Technology (US$ Million)
9.5.5.3 Rest of South and Central America: Veterinary Vaccines Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Rest of South and Central America: Veterinary Vaccines Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.2 Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.3.2.1 Rest of South & Central America: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.5.5.3.2.2 Rest of South & Central America: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10. Impact of COVID-19 Pandemic on Global Veterinary Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Veterinary Vaccines Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zoetis Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Virbac
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BIOVAC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NEOGEN Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 HIPRA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ceva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hester Biosciences Limited
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Veterinary Vaccines Market, by Companion Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. US Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Veterinary Vaccines Market, by Companion Animal Vaccines– Revenue and Forecast to 2028 (US$ Million)
Table 8. US Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Mn).
Table 18. Europe Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 21. Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
Table 22. Germany Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 23. Germany Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 24. Germany Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 25. France: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 26. France Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 27. France Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 28. France Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 30. UK Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 31. UK: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 32. UK: Veterinary Vaccines Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 34. Italy Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 36. Italy Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 38. Spain Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 40. Spain Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 49. China: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 50. China Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 51. China Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 52. China Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 55. Japan Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 56. Japan Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 57. India: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 58. India: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 59. India: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 60. India Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 62. Australia: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 64. Australia Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 80. Saudi Arabia Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 81. UAE Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 82. UAE Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 83. UAE Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 84. UAE Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 88. South Africa Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa Veterinary Vaccines Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of Middle East & Africa Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America: Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Veterinary Vaccines Market, by Companion Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 98. Brazil: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Veterinary Vaccines Market, by Companion Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 102. Argentina: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Veterinary Vaccines Market, by Companion Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 105. Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 106. Rest of South & Central America: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South & Central America: Veterinary Vaccines Market, by Companion Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Veterinary Vaccines Market
LIST OF FIGURES
Figure 1. Veterinary Vaccines Market Segmentation
Figure 2. Veterinary Vaccines Market, By Region
Figure 3. Global Veterinary Vaccines Market Overview
Figure 4. Livestock Vaccines Segment Held Largest Share of Vaccine Type Segment in Veterinary Vaccines Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Veterinary Vaccines Market, by Geography (US$ Million)
Figure 7. Global Veterinary Vaccines Market- Leading Country Markets (US$ Million)
Figure 8. Global Veterinary Vaccines Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Veterinary Vaccines Market
Figure 16. Global Veterinary Vaccines Market– Revenue Forecast and Analysis – 2021 – 2028..
Figure 17. Global Veterinary Vaccines Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Veterinary Vaccines Market
Figure 19. Global Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
Figure 20. Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Global Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
Figure 29. Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 35. North America Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 37. US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)...
Figure 39. Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)....
Figure 40. Europe: Veterinary Vaccines Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 41. Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)..
Figure 43. Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 44. France: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia Pacific: Veterinary Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 50. Asia Pacific Veterinary Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Asia Pacific: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 52. China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Rest of Asia Pacific: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Middle East & Africa: Veterinary Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 59. Middle East & Africa Veterinary Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 60. Middle East & Africa: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 61. Saudi Arabia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
Figure 65. South and Central America Veterinary Vaccines Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 66. South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
Figure 68. Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)...
Figure 70. Rest of South and Central America: Veterinary Vaccines Market– Revenue and Forecast to 2028 (USD Mn)
Figure 71. Impact of COVID-19 Pandemic in North American Country Markets
Figure 72. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets..
Figure 76. Growth Strategies Done by the Companies in the Market (%)
The List of Companies - Veterinary Vaccines Market
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
- ImmuCell Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Veterinary Vaccines Market
Dec 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Dec 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Dec 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)